Considering the importance of the pleotropic impacts of SMYD2 on cancer biology [15,16,17,18] and the hypothesis that targeting SMYD2 may impair the PC recurrence, the current study reports the novel role of SMYD2 in mCRPC pathogenesis. Here, SMYD2 is linked to cancer.